絞り込み

16525

広告

Initial strides for invent-VTE: Towards global collaboration to accelerate clinical research in venous thromboembolism.

著者 Rodger M , Langlois N , Middeldorp S , Kahn S , Sandset PM , Brighton T , Huisman M , Meyer G , Konstantinides S , Ageno W , Morange P , Garcia D , Kreuziger LB , Young L , Key N , Monreal M , Jiménez D
Thromb Res.2018 Jan 31 ; 163():128-131.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (82view , 0users)

Full Text Sources

Venous thromboembolism (VTE) represents a major global burden of disease and requires collaborative efforts to conduct large, high-quality investigator-initiated and academically sponsored studies addressing the most relevant clinical questions. Owing to increasing regulatory requirements, the highly competitive nature of peer-reviewed funding and costs associated with conducting large, multinational clinical trials, completing practice-changing research constitutes a growing challenge for clinical investigators. As clinical trialists interested in VTE, we founded INVENT (International Network of Venous Thromboembolism Clinical Research Networks) in an effort to promote and accelerate patient-oriented, investigator-initiated, international collaborative research, to identify, prioritize and answer key clinical research questions for patients with VTE. We report on our activities to formalize the INVENT network and our accomplishments in our first year.
PMID: 29407624 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード